DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $124,000 | +6.9% | 31,013 | +31.2% | 0.00% | – |
| Q3 2019 | $116,000 | -19.4% | 23,641 | 0.0% | 0.00% | – |
| Q2 2019 | $144,000 | +5.1% | 23,641 | 0.0% | 0.00% | – |
| Q1 2019 | $137,000 | -56.9% | 23,641 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $318,000 | -26.0% | 23,641 | +6.6% | 0.00% | 0.0% |
| Q3 2018 | $430,000 | -24.2% | 22,172 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $567,000 | +30.0% | 22,172 | +2.5% | 0.00% | 0.0% |
| Q1 2018 | $436,000 | +0.5% | 21,641 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $434,000 | -3.1% | 21,641 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $448,000 | +40.0% | 21,641 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $320,000 | +2.2% | 21,641 | +10.4% | 0.00% | 0.0% |
| Q1 2017 | $313,000 | +26.7% | 19,601 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $247,000 | -55.0% | 19,601 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $549,000 | -20.0% | 19,601 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $686,000 | +60.7% | 19,601 | +25.7% | 0.00% | +100.0% |
| Q1 2016 | $427,000 | -20.0% | 15,595 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $534,000 | +19.2% | 15,595 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $448,000 | -42.6% | 15,595 | -10.5% | 0.00% | -50.0% |
| Q2 2015 | $780,000 | +167.1% | 17,434 | +106.5% | 0.00% | +100.0% |
| Q1 2015 | $292,000 | +26.4% | 8,443 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $231,000 | – | 8,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|